This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Incorporated in Delaware in 1923, Archer Daniels Midland Company is successor to the Daniels Linseed Co. Founded in 1902, this Illinois-based company is one of the leading producers of food and beverage ingredients as well as goods made from various agricultural products. The company processes oilseeds, corn, wheat, cocoa and other feedstuffs. Moreover, it engages in the manufacturing, sale, and distribution of products like natural flavor ingredients, flavor systems, natural colors, proteins, emulsifiers, soluble fiber, polyols, hydrocolloids, natural health and nutrition products as well as other specialty food and feed ingredients.
4 Reasons Why Boston Beer (SAM) Must Be in Your Portfolio
by Zacks Equity Research
Boston Beer (SAM) shows resilience, driven by progress on three-point growth plan, focused on cost-saving initiatives, long-term innovation, and revival of Samuel Adams and Angry Orchard brands.
The Zacks Analyst Blog Highlights: Advance Auto Parts, Atlas Air Worldwide Holdings, ABIOMED, Archer-Daniels-Midland and Amerisafe
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Advance Auto Parts, Atlas Air Worldwide Holdings, ABIOMED, Archer-Daniels-Midland and Amerisafe
Top Ranked Income Stocks to Buy for October 15th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, October 15th:
Archer Daniels Midland (ADM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Archer Daniels Midland (ADM) closed the most recent trading day at $48.83, moving +0.33% from the previous trading session.
Why ADM (ADM) Could Beat Earnings Estimates Again
by Zacks Equity Research
ADM (ADM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
5 of the Best Stocks to Buy for a Resurgent Wall Street
by Tirthankar Chakraborty
As the broader market is ready for a counter-trend bounce, it is the ideal time to bet on stocks that are sound enough to grow in the near term.
Archer Daniels (ADM) Rallies 31% YTD on Sound Strategies
by Zacks Equity Research
Archer Daniels (ADM) looks promising owing to its robust growth strategies, including cost savings, management of business portfolio and Project Readiness program.
New Strong Buy Stocks for October 10th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Wednesday
Is Archer Daniels (ADM) a Great Stock for Value Investors?
by Zacks Equity Research
Let's see if Archer Daniels (ADM) stock is a good choice for value-oriented investors right now from multiple angles.
6 Defensive Stocks to Combat Rate Spike Fears
by Swarup Gupta
Since these also hold the promise of higher-than-average yields, investing in defensive stocks looks like a prudent option.
Newell (NWL) Slides to 52-Week Low: Soft Margins to Blame?
by Zacks Equity Research
Newell (NWL) is struggling with a dismal margins trend for the past few quarters, despite gains from cost synergies and savings.
Zacks.com highlights: Colfax, United Therapeutics, Trinseo, Xilinx and Archer Daniels Midland
by Zacks Equity Research
Zacks.com highlights: Colfax, United Therapeutics, Trinseo, Xilinx and Archer Daniels Midland
5 Stocks Trading Near 52-Week High With More Upside in Store
by Zacks Equity Research
Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.
Constellation Brands (STZ) Q2 Earnings Beat, FY19 EPS View Up
by Zacks Equity Research
Constellation Brands (STZ) posts robust second-quarter fiscal 2019 results. Also, management raised its adjusted and GAAP view for the fiscal year.
New Strong Buy Stocks for October 4th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
Clorox's Annual Report Reveals Significant Progress, Stock Up
by Zacks Equity Research
Clorox (CLX) issues its integrated annual report for fiscal 2018, which marks the seventh consecutive year of the release.
USMCA (aka NAFTA 2.0): Here Are the Winners & Losers
by Tirthankar Chakraborty
Who's smiling and who's not as the world witnesses the making of the new NAFTA?
The Zacks Analyst Blog Highlights: Acelor Mittal, Archer Daniels Midland and Nucor
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Acelor Mittal, Archer Daniels Midland and Nucor
All About the JOBS Report: Global Week Ahead
by John Blank
This Global Week Ahead should key largely on a looming U.S. jobs report. Friday's U.S. nonfarm payroll release for September may show us two things.
Is Archer Daniels Midland (ADM) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Is (ADM) Outperforming Other Consumer Staples Stocks This Year?
Can Clorox's (CLX) Growth Strategies Offset Margin Woes?
by Zacks Equity Research
Clorox's (CLX) solid growth strategies, including 2020 Strategy, bode well. These initiatives are likely to offset margin pressures moving ahead.
Trump Clinches Trade Deal With South Korea: 6 Winning Picks
by Swarup Gupta
Trump claims that U.S. auto, pharma and agricultural products will gain from the deal with South Korea.
5 Defensive Stocks to Buy as Trade Tensions Take a New Turn
by Ritujay Ghosh
Given that both the United States and China are imposing tit-for-tat tariffs, the trade war is unlikely to end anytime soon.
Avon Stock Rallies on Takeover Talks With Brazil's Natura
by Zacks Equity Research
Avon (AVP) gains on rumors of a possible buyout by Natura & Co, the leading Brazilian cosmetics company.
4 Reasons Why You Should Invest in Archer Daniels Stock
by Zacks Equity Research
Archer Daniels' (ADM) progresses on its portfolio management initiatives, cost-savings plan and Readiness program bodes well.